ESKER THERAPEUTICS, INC. November 12, 2021Form of Release Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
We are pleased to present this offer of employment for the position of Vice President, Program Management of Esker Therapeutics, Inc. (the “Company”). This is a full-time, exempt position, carrying considerable responsibility and is integral to the development and success of the Company’s business. We are excited about your interest in joining the Company full-time. This letter agreement formally presents the specifics of our offer for your consideration:
ContractAlumis Inc. • May 15th, 2024 • Pharmaceutical preparations
Certain information has been excluded from this agreement (indicated by “[***]”) because such information is both not material and the type that the registrant customarily and actually treats as private or confidential.
AMENDMENT TO OFFER LETTEROffer Letter • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations • California
This Amendment to Offer Letter is made and entered into effective as of July 17, 2023 (the “Amendment Effective Date”), by and between Alumis Inc., a company organized under the laws of Delaware (the “Company”), and its Chief Development Officer Mark Bradley.
LEASE AGREEMENTLease Agreement • May 15th, 2024 • Alumis Inc. • Pharmaceutical preparations
THIS LEASE AGREEMENT (this “Lease”) is made this ____ day of July, 2021, between 611 GATEWAY CENTER LP, a Delaware limited partnership (“Landlord”), and ESKER THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
